COCH logo

ENVOY MEDICAL INC

COCHNASDAQ
🏆 #4880 by market capEarnings Nov 9US Equity
$82.39▼ $1.58 (−1.92%)
Simulated price
🔔
Track COCH
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 1.9%
7d▲ 11243.8%
14d▲ 11186.3%
30d▲ 11478.1%
ytd▲ 12100.5%
1y▲ 10341.0%
🏦Market Cap
$14M
Small Cap
📈Revenue Growth (YoY)
+7.1%
Slowing
📊Gross Margin
-385.5%
Thin
💵FCF Margin
-10488.4%
Thin
⚖️P/S Ratio
69.5x
Expensive
Otter Score
60
Fair

Trading Snapshot

Day Range
$81.45 – $83.24
52-Week Range
$0.36 – $1.89
Volume
$3.05B
Avg Volume
$3.48B
Shares Outstanding
20.8M
Next Earnings
Nov 13, 2026

Fundamentals Snapshot

Annual Revenue
$241,000
Last Q Revenue
$51,000
P/E Ratio
-1.0
P/S Ratio
69.5x
EPS (TTM)
$-0.22
Dividend Yield
0.00%
Dilution (1yr)
+116.1%

Why Investors Own COCH

  • ✓High-growth profile — revenue up +19.9% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 41% gross margin and 13% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

COCH logo

ENVOY MEDICAL INC

COCH
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$241K▲ +7.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-262.7%▲ +14.3% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$22M▲ +15.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$18M▼ −2.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
46.1M▲ +116.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$3M▲ +$17M YoY
StockOtter · stockotter.space

About ENVOY MEDICAL INC

Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
60/100

Analyst Ratings

ⓘ
Consensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

🚀
Bloomberg·2h ago

ENVOY MEDICAL INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Reuters·5h ago

Analysts lift COCH price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Reuters·1d ago

ENVOY MEDICAL INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.